Assessment of a modified Coronavirus Disease Optimization Algorithm for Parameter Estimation of Proton Exchange Membrane Fuel Cells.

Publication date: May 22, 2026

Parameter identification of a proton exchange membrane fuel cell (PEMFC) involves estimating the unknown model parameters required to build an accurate predictive representation of fuel-cell performance using optimization-based techniques. Because these parameters are often unavailable in manufacturer datasheets, their estimation is crucial for reliable performance prediction and system evaluation. In this work, a memory-based Coronavirus Disease Optimization Algorithm (mCOVIDOA) is proposed as an enhanced optimization method for extracting PEMFC parameters. Six unknown model parameters are identified and compared using six optimization approaches: mCOVIDOA, the standard Coronavirus Disease Optimization Algorithm (COVIDOA), Tunicate Swarm Algorithm (TSA), Grey Wolf Optimizer (GWO), Chimp Optimization Algorithm (ChOA), and Moth-Flame Optimizer (MFO). During the optimization process, these parameters are treated as decision variables, and the objective is to minimize the sum of squared errors (SSE) between simulated and measured cell voltages. The results show that mCOVIDOA achieves a lower SSE (1. 9454) and consistently outperforms the original COVIDOA as well as GWO, TSA, ChOA, and MFO in terms of convergence quality and solution accuracy. Owing to its accurate prediction capability and faster convergence, mCOVIDOA shows strong potential for digital-twin development of fuel-cell systems and advanced control applications in automotive energy systems.

Open Access PDF

Concepts Keywords
Coronavirus Algorithms
Proton COVID-19
Reliable Estimation
Wolf Fuel cell
Humans
Models, Theoretical
Protons
Protons

Semantics

Type Source Name
pathway KEGG Coronavirus disease
drug DRUGBANK Sulpiride
drug DRUGBANK Activated charcoal
drug DRUGBANK Coenzyme M
disease MESH BCS
disease MESH AOA
drug DRUGBANK Honey
drug DRUGBANK Flunarizine
disease MESH face
drug DRUGBANK Isoxaflutole
pathway KEGG Viral replication
drug DRUGBANK Oxygen
pathway REACTOME Translation
pathway KEGG Ribosome
pathway REACTOME Immune System
disease MESH influenza
disease MESH infection
disease MESH Dis
drug DRUGBANK Phenindione
pathway REACTOME Reproduction
disease MESH included
disease MESH COVID-19

Original Article

(Visited 3 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *